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Skin protects itself against infection through a variety
of mechanisms. Antimicrobial peptides (AMPs) are
major contributors to cutaneous innate immunity, and
this system, combined with the unique ionic, lipid,
and physical barrier of the epidermis, is the first-line
defense against invading pathogens. However, recent
studies have revealed that our skin’s innate immune
system is not solely of human origin. Staphylococcus
epidermidis, a major constituent of the normal
microflora on healthy human skin, acts as a barrier
against colonization of potentially pathogenic mi-
crobes and against overgrowth of already present
opportunistic pathogens. Our resident commensal
microbes produce their own AMPs, act to enhance the
normal production of AMPs by keratinocytes, and are
beneficial to maintaining inflammatory homeostasis
by suppressing excess cytokine release after minor
epidermal injury. These observations indicate that the
normal human skin microflora protects skin by
various modes of action, a conclusion supported by
many lines of evidence associating diseases such as
acne, atopic dermatitis, psoriasis, and rosacea with an
imbalance of the microflora even in the absence of
classical infection. This review highlights recent
observations on the importance of innate immune
systems and the relationship with the normal skin
microflora to maintain healthy skin.
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ANTIMICROBIAL PEPTIDES IN SKIN INNATE IMMUNITY
The skin provides the first line of immune defense against
invading pathogens and both passively and actively protects
the surface through various modes of action. One critical
mechanism for self-protection is the innate production of
antimicrobial peptides (AMPs) by the epidermis. These
molecules are produced in all organs by a variety of cell
types and are major contributors to immune defense (Nizet
et al., 2001; Zasloff, 2002). In human skin, the main sources
of AMPs are keratinocytes, mast cells, neutrophils, and
sebocytes. Because of their direct antimicrobial action, one
mechanism of defense by AMPs is that the secretion or
release of these peptides provides innate antibiotic-like
action against infectious pathogens. AMPs such as the
cathelicidin LL-37 also function by triggering inflammatory
cell recruitment and cytokine release. AMPs can be produced
constitutively, or actively induced upon sensing of danger,
and this system often involves signaling mediated by pattern
recognition receptors such as Toll-like receptors (TLRs) or
responses to pro-inammatory cytokines (Lai and Gallo, 2009).
Keratinocytes are the main source of AMPs in normal
human skin, but once inflamed the recruited leukocytes
contribute the majority of antimicrobial activity. There are
many AMPs in human skin but cathelicidins and b-defensins
are the most well characterized (Lai and Gallo, 2009;
Wiesner and Vilcinskas, 2010). Human b-defensin (hBD)-1
is constitutively expressed in keratinocytes, but exhibits only
minor antibiotic killing activity in comparison with other
defensins (Zaalouk et al., 2004; Yadava et al., 2006). More
recently, the reduced form of hBD-1 has been shown to
become a potent AMP, of which reduction is catalyzed by
thioredoxin expressed in the epidermis (Schroeder et al.,
2011). This suggests that the redox regulation is crucial for the
innate immune protection by hBD-1. The expression levels of
hBD-2, hBD-3, and human cathelicidin in keratinocytes are
very low at the steady state and typically upregulated during
infection, inflammation, and wounding then accumulate in
the skin (Gallo et al., 2002; Froy, 2005). This suggests that the
increase in AMP is a secondary response to limit the severity
of clinical symptoms when the primary line of defense
(constitutive expression of AMPs) fails. Human keratinocytes
also express proteins with antimicrobial activity that includes
ribonucleotidases (RNases) 1, 4, 5, and 7. Of these, RNases 5
and 7 exhibit antimicrobial activity against many pathogenic
microorganisms independent of the RNase activity, which is
due to pore formation and disruption of the bacterial
membrane (Huang et al., 2007; Abtin et al., 2009; Zanger
et al., 2009). The antimicrobial activity of those RNases is
inhibited by RNase inhibitor protein expressed in epidermal
keratinocytes, and, in turn, activated when the RNase
inhibitor is cleaved by stratum corneum serine proteases
(Abtin et al., 2009). An antimicrobial heterodimeric complex,
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S100A8/S100A9 (calprotectin), is induced in epidermal
keratinocytes during Gram-negative bacteria infection and
sensing of bacterial flagellin by TLR5 is critical for the
regulation of calprotectin (Abtin et al., 2010). In other aspects
of role of AMPs in innate immunity, altered expression of
AMPs can have a role in the pathogenesis of chronic
inflammatory skin disorders, such as atopic dermatitis,
psoriasis, and rosacea (see below; Yamasaki and Gallo,
2008).
Recent evidence has indicated that human sebaceous
glands also contribute to skin immune defense by releasing
AMPs. Cathelicidin, hBD-2, and antimicrobial histone H4 are
detected in the cultured human sebocytes, and their
expression levels are upregulated in the presence of Gram-
positive bacteria (Nagy et al., 2006; Lee et al., 2008, 2009).
Large amounts of psoriasin accumulate in the epidermis of
sebaceous skin as well as in sebaceous glands, suggesting that
psoriasin is possibly secreted along with sebum lipids (Glaser
et al., 2005). In addition to the AMPs, other molecules also
add to the antimicrobial barrier formed by sebocytes. Free
fatty acids (FFAs) are ubiquitously found on the surface of
human skin and are the most predominant components in
human sebum. FFAs are produced by lipases that are secreted
from the commensal bacterial flora such as Propionibacter-
ium acnes and Staphylococcus epidermidis by hydrolyzing
sebum triacylglycerides secreted from sebaceous glands
(Marples et al., 1971; Holland et al., 1981; Gotz et al.,
1998), but can also be produced by sebocytes without the
presence of bacteria (Fujie et al., 1996; Zouboulis et al.,
1999). Because some middle- to long-chain FFAs (C8–C18)
have shown antibacterial activity against a broad range of
Gram-positive bacteria (Skrivanova et al., 2005; Drake et al.,
2008; Nakatsuji et al., 2009), they have been thought to be
responsible for at least a part of the direct antimicrobial
activity of the skin surface against pathogen colonization and
infection. In addition to the direct antimicrobial activity,
lauric acid (C12:0), palmitic acid (16:0), and oleic acid
(C18:1, cis-9), representative sebum FFAs, enhance the skin
innate immune defense by inducing hBD-2 in the human
sebocytes (Nakatsuji et al., 2010). Therefore, the sebaceous
glands may have a very significant role in skin in innate
immunity by providing antimicrobial agents to the external
skin surface.
Eccrine glands are also known as an important supplier of
AMPs to the epidermal surface. Dermcidin is an AMP,
constitutively, expressed as a small precursor protein in
eccrine sweat glands and secreted into sweat where active
AMPs are proteolytically generated (Schittek et al., 2001).
Although dermcidin-derived AMPs do not induce pore
formation on the bacterial cell membrane in contrast to the
mode of action of classic AMPs, they bind to unidentified
targets of bacterial cell envelope, resulting in reduced RNA
and protein synthesis (Senyurek et al., 2009).
ANTIMICROBIAL PEPTIDES PRODUCED BY SKIN
COMMENSAL BACTERIA
A surprising recent revelation is that the AMPs that occupy
the surface of our skin are made not only by our own cells,
but also in prokaryotic organisms that inhabit our epidermis.
A large number of Gram-positive bacteria, such as Lacto-
coccus, Streptococcus, and Streptomyces species have been
known to produce factors to inhibit other bacteria (Bastos
et al., 2009). Proteinaceous factors produced by bacteria
with bactericidal activity against the growth of similar or
closely related bacterial strains are called bacteriocins.
S. epidermidis, the dominant commensal bacterium cultured
from the skin microflora, produces various types of bacteriocins.
Most of these peptides are encoded in plasmids. Epidermin,
Pep5, and epilancin K7 are the most characterized bacter-
iocins isolated from S. epidermidis (Bastos et al., 2009).
Because these peptides contain the thioether amino acids
lanthionine and/or methyllanthionine, they are classified as
lantibiotics. These modified amino acids form three ring
structures, which are important for their bactericidal activity.
Their bactericidal action is thought to predominantly involve
pore formation on bacterial cell membranes, which is similar
to mammalian AMPs like defensins and cathelicidins.
Because of their potential to kill pathogens in vitro, these
bacteriocins may possess the capacity to provide antimicro-
bial protection against pathogens on the skin surface.
In spite of a number of studies regarding antimicrobial
activity of bacteriocins in vitro, to our knowledge, little effort
has been made to demonstrate how bacteriocin-producing
bacteria contribute skin innate immune defense. Our group
has first proposed that the unique peptides, phenol-soluble
modulin (PSM)g and PSMd, produced by S. epidermidis could
be beneficial to the host and thus serve as additional AMPs on
normal skin surface (Cogen et al., 2010b). These peptides
possess two opposing sides organized by their hydrophobic
and cationic amino acids with a five-amino-acid periodicity,
a strategy for action of both a hydrophilic and hydrophobic
molecule that resembles that of classic AMPs such as LL-37.
Classic AMPs, such as LL-37 and hBDs, are also amphipathic
molecules that possess clusters of positively charged and
hydrophobic charged amino-acid chains. This feature is
thought to allow them to interact with negatively charged
phospholipid head groups and hydrophobic fatty acid chains
of microbial membranes, resulting in pore formation on the
microbial membrane and releases cytosol components
(Glaser et al., 2005; Wimley, 2010). In fact, PSMs caused
membrane leakage and membrane perturbation in bacteria,
suggesting that these peptides function in a similar mechan-
istic manner as that of innate cutaneous AMPs. These
peptides selectively exhibited bactericidal activity against
skin pathogens, such as Staphylococcus aureus, group A
Streptococcus, and E. coli, whereas they are not active
against S. epidermidis. Moreover, inoculating PSMs on the
mouse skin surface reduced group A Streptococcus but not
the survival of S. epidermidis. This selective activity is likely
to be an important part of a normal microbial defense strategy
against colonization. In addition, PSMs will enhance the
antimicrobial activity of the host AMPs, such as LL-37,
CRAMP, and hBDs. More recently, it has been demonstrated
that PSMa1 and PSMa2 isolated from methicillin-resistant
S. aureus exhibit only a weak antimicrobial activity, but their
antimicrobial activities are in turn considerably enhanced
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when their N-terminal is proteolytically cleaved, indicating
that the N-terminal can act as a negative regulator of
antimicrobial activity (Joo et al., 2011). However, it remains
unclear how the PSMs are proteolytically activated. In
addition, S. aureus PSMs show chemotactic activity for
neutrophils through formyl peptide receptor 2 and then
induce lysis of the infiltrated neutrophils presumably by a
local high concentration of PSMs (micromolar order), which
may contribute to the pathogenicity of S. aureus (Wang et al.,
2007; Kretschmer et al., 2010). However, S. epidermidis
PSMs do not induce lysis of neutrophils at micromolar
concentrations, but enhance the capacity of their bacteria-
killing activity as described below (Cogen et al., 2010a). In
addition, proinflammatory properties of S. epidermidis PSMs
have been reported (Mehlin et al., 1999; Vuong et al., 2004).
Thus, staphylococcus PSMs can have roles in both innate
immune defense and pathogenesis. Similarly, host AMPs such
as LL-37 can also lead to disease when abnormally expressed
(described below). It is likely that S. epidermidis PSMs are
beneficial when present on the surface of intact skin, but
become potentially pathogenic to the host when the
interaction between commensals and host innate immunity
is imbalanced.
The AMPs released by resident microbes are not a minor
component of the epidermal antimicrobial milieu. S. epider-
midis PSMg was abundantly detectable in the normal human
epidermis, hair follicle, and sparsely in the dermis (Cogen
et al., 2010a). PSMs in nanomolar amounts decreased group
A Streptococcus survival on normal human skin by 2–3 log
abundance. PSMg added to the freshly isolated human
neutrophils could also be incorporated into the neutrophil
extracellular traps and facilitated eradication of potentially
dangerous bacteria. Incorporated PSMg into the neutrophil
extracellular traps was colocalized with cathelicidin AMP
endogenously released from the cell. Furthermore, addition
of PSMg to cultured neutrophils induced their neutrophil
extracellular trap formation. These observations strongly
support the concept that S. epidermidis contributes actively
to the skin innate immune defense by supplying additional
AMPs that act together with the host-derived AMPs.
More recently, it has been demonstrated that the presence
of S. epidermidis on the nasal cavity is clinically relevant. The
rate of nasal colonization by S. aureus was significantly lower
in individuals in the presence of inhibitory S. epidermidis
strains that are capable to inhibit biofilm formation by
S. aureus (Iwase et al., 2010). These inhibitory S. epidermidis
strains secreted a S. epidermidis serine protease that inhibits
biofilm formation and destroys biofilms formed by S. aureus.
Furthermore, inoculation of inhibitory S. epidermidis in the
human nasal cavity eliminated S. aureus colonization. In
addition, a thiolactone-containing peptide and its derivatives
produced by S. epidermidis blocks the S. aureus agr quorum-
sensing system, which controls production of various
virulence factors (Otto et al., 1999). Because S. epidermidis
is the most prevalent of cutaneous resident microflora and
S. aureus is a transient resident in healthy skin, such an
intraspecies competition may be involved in maintaining the
homeostasis of skin microflora.
MICROBIAL SYMBIOSIS AND IMMUNITY: ROLES OF
MICROBES IN SKIN HOMEOSTASIS
The human body engages in symbiotic associations with vast
and complex microbial communities. The major habitats for
human indigenous microbiota are the oral cavity, orophar-
ynx, gastrointestinal tract, vagina, and skin. Recent studies
demonstrated that symbiotic factors produced by intestinal
commensal bacteria beneficially modulate the host immune
systems, decreasing a risk of autoimmune diseases and/or
inflammation induced by infections. Mazmanian et al. (2008)
demonstrated that polysaccharide A produced by Bacteroides
fragilis suppressed proinflammatory IL-17 production by
intestinal immune cells exposed to pathogenic bacteria,
Helicobacter pylori, through a functional requirement for
IL-10-producing CD4þ T cells. Maslowski et al. also
demonstrated short-chain fatty acids, which are produced
by fermentation of dietary fiber by intestinal microbiota,
suppressed inflammation by reducing activity and recruit-
ment of neutrophils through binding to G-protein-coupled
receptor-43 (also known as FFA receptor 2) on the cell
surface (Maslowski et al., 2009). The G-protein-coupled
receptor-43 signaling suppressed colitis, arthritis, and allergic
airway inflammation on the mouse models.
On the skin microenvironment much less research has
been directed toward determining whether the resident
microbiota of normal human skin, or specific elements from
commensal bacteria, influence cutaneous immune systems
and host–pathogen interactions. Our group has demonstrated
for the first time a mutually beneficial relationship between
S. epidermidis and keratinocyte inflammatory responses. In
this work, it was shown that a unique lipoteichoic acid
produced by S. epidermidis inhibits uncontrolled skin
inflammation during skin injury, which in this case delays
wound repair (Lai et al., 2009). After skin injury, the host
RNA from damaged cells activates TLR3 in the keratinocytes,
which accounts for the release of inflammatory cytokines,
resulting in inflammation. Staphylococcal lipoteichoic acid
inhibits both inflammatory cytokine release from keratino-
cytes and inflammation triggered by injury through a TLR2-
dependent mechanism (Figure 1). Other mutually beneficial
interactions also appear to exist between keratinocytes and
S. epidermidis. For example, a small molecule of o10 kDa
secreted from S. epidermidis increased expression of hBDs in
murine skin or human keratinocytes through TLR2 signaling
(Lai et al., 2010). Similarly, co-cultivation of differentiated
human primary keratinocytes with live S. epidermidis, but not
heat-inactivated bacteria, enhances production of hBD-2,
hBD-3, and RNase7. In addition, the keratinocytes pre-
incubated with S. epidermidis-conditioned media strongly
enhances AMP production induced by S. aureus, suggesting
that S. epidermidis sensitizes human keratinocytes toward
pathogenic bacteria and amplifies the innate immune
response (Wanke et al., 2011). Thus, the recognition of
staphylococcal molecule by TLR2 may be involved in the
steady-state production of AMPs in keratinocytes and
enhances resistance to infection by bacterial, fungal,
and viral pathogens. Contrary to these reports, live S.
epidermidis suppresses AMP expressions in a human living
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skin equivalent model in vitro for a 24-hour incubation when
the inoculated bacteria keep on growing (Holland et al.,
2008, 2009). Thus, S. epidermidis may also have capacity to
evade innate immune defense during growth phase, as it can
become an opportunistic pathogen. The balance of evading
and stimulating innate immune defense has important
consequences for skin homeostasis.
SKIN DISORDERS ASSOCIATED WITH DYSBIOSIS
Because the human skin provides environmental niches that
greatly differ in humidity, temperature, oiliness, and aero-
bicity, and these influence the survival of resident microbial
flora, the skin-resident microflora are highly diverse. Culture-
based techniques performed in seminal studies over 30 years
ago clearly identified some of the organisms that survive
different skin microenvironments (Kloos and Musselwhite,
1975). Newer 16S rRNA gene sequencing approaches have
expanded the complexity of the microbial community and
further established that the capacity to detect microbes is
dependent on the specific characteristics of the skin site
sampled. Grice et al. (2009) have characterized the
topographical and temporal diversity of microbiome in the
healthy human skin of a small population of individuals with
a 16S rRNA gene phylotyping. In the sebaceous sites,
Propionibacteria species were the most predominant fol-
lowed by Staphylococci species. In the moist sites, Coryne-
bacteria and Staphylococci species predominated, though b-
Proteobacteria also were represented. In the dry sites, a
mixed population of bacteria resided with a greater pre-
valence of b-Proteobacteria and Flavobacteriales species. The
microbial profile (Microbiome) observed was of much greater
diversity than that revealed by classical culture-based
methods, reflecting the increased sensitivity of this technique,
the lack of dependence upon culture techniques, and the
capacity to detect non-living bacteria that may have only
transiently resided at the site. This topographical and
temporal survey has provided a baseline for studies that
examine which bacterial communities contribute to disease
states and the microbial interdependencies required to
maintain healthy skin.
Based on even the early information compiled in the last
1–2 years it is reasonable to hypothesize that disrupting the
normal skin microbial flora, either by indiscriminant topical
cleaners or by systemic antibiotic exposure, could upset
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Figure 1. Molecular interactions of microbial symbiosis in skin innate immune systems. Factors produced by skin commensal bacteria modulate the skin
immune system. (a) In a steady state, Staphylococcus epidermidis, a major constituent of the normal microflora on healthy human skin, produces antimicrobial
peptides, phenol-soluble modulin (PSM)d and PSMg, which act as a barrier against colonization of potentially pathogenic microbes. In addition, S. epidermidis
secretes a small molecule, which increases expression of defensins in murine skin or human keratinocytes through TLR2 signaling. (b) After skin injury, host RNA
from damaged cells activates TLR3 in keratinocytes. If uncontrolled inflammation occurs this can result in delayed wound healing. Staphylococcal LTA inhibits
excess inflammatory cytokine release from keratinocytes and inflammation through a TLR2-dependent mechanism. IRF, IFN-regulatory factor; JNK, C-Jun
N-terminal kinase; LTA, lipoteichoic acid; MyD88, myeloid differentiation primary response gene 88; TLR, Toll-like receptor; TRAF, tumor necrosis factor
receptor-associated factor; TRIF, TIR-domain-containing adapter-inducing IFN-b.
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skin immune defense. Many lines of evidence associate
pathogenicity with an imbalance of microorganisms, known
as dysbiosis. Such evidence has been classically assembled in
several noninfectious skin diseases such as acne vulgaris,
atopic dermatitis, psoriasis, and rosacea (Table 1). Recent
observations indicate that altered production of AMPs in the
skin is implicated in the pathogenesis of psoriasis, rosacea,
and atopic dermatitis. Cathelicidins and hBDs are strongly
induced in psoriatic lesions in comparison with normal skin,
but the induction of AMPs is much lower in atopic dermatitis
lesions in comparison with the psoriatic lesion, despite the
presence of skin inflammation (Ong et al., 2002; Lande et al.,
2007; Hata et al., 2010). In atopic dermatitis lesions, the
cathelicidin expression is downregulated following acute
wounding (Mallbris et al., 2010). RNase7 and psoriasin are
also induced in atopic dermatitis lesional skin and the AMP
induction is upregulated by barrier disruption (Harder et al.,
2010). Thus, in atopic disease, the normal induction of some
but not all AMPs is inhibited, a phenomenon that is thought
to contribute to the susceptibility of atopics to infection. In
rosacea, an excess of cathelicidin in the form of LL-37 drives
inammation and abnormal blood vessel growth by mechan-
isms of cell activation (Yamasaki et al., 2007). In addition,
abnormal functions of innate immune pattern recognition by
overexpressed TLRs have been observed in the epidermis of
the patients with these disorders (Bensch et al., 1995; Jugeau
et al., 2005; Yamasaki et al., 2011). These disturbed innate
immune systems would impact the homeostasis of skin-
resident microflora, which may disrupt skin barrier and
induce abnormal inflammatory responses. In fact, although
P. acnes is a member of the normal skin commensal bacterial
flora, it has a critical role in the development of inflammatory
acne when it overgrows in the pilosebaceous unit (Cunliffe
and Gollnick, 2001; Bojar and Holland, 2004). In the
psoriatic lesions, the representation of Propionibacterium
and Actinobacteria species were lower than normal control
skin. In contrast, Firmicutes species were overrepresented in
the psoriatic lesions (Gao et al., 2008). Thus, psoriasis may
be, in part, associated with substantial alteration in the
composition and representation of the cutaneous microflora.
However, psoriasis patients are known to rarely suffer from
skin infections by pathogens, which may be explained by an
overexpression level of AMPs in psoriatic lesions. Although
no specific pathogenic organisms were isolated in the
lesional skin of rosacea (Marks, 1968), implication of
dysbiosis in the pathogenesis of rosacea has been explored.
As an example, predominance of S. epidermidis was
observed in the lesional skins of pustular and ocular rosacea
in comparison to peripheral non-lesional skin, whereas other
bacteria were recovered at much lower levels from lesional
skin (Whitfeld et al., 2011). Perhaps the best and most well-
established example of dysbiosis is in atopic dermatitis.
Bacterial infections are extremely common in atopic derma-
titis patients. Colonization of S. aureus is known to have an
important roles in the exacerbation of the infection and is
correlated with its extent and severity (Miller et al., 2005),
which can be explained by defective expression of AMPs in
atopic lesions.
CONCLUSIONS
Recent studies have revealed that the skin innate immune
system work is together with the cutaneous microbiota to act
as a barrier against pathogenic microbes and against over-
growth of opportunistic pathogens. Antibiotics are conven-
tionally used as treatment for various skin infectious diseases
such as acne vulgaris and atopic dermatitis. However,
antibiotic therapy nonspecifically kills a variety of bacteria,
which may impact the homeostasis derived from the
Table 1. Skin diseases associated with dysbiosis: relevance between innate immunity and microbiome
Disease Innate immunity disorder Abnormality of skin microbiota References
Inflammatory
acne vulgaris
Upregulation of hBDs
Upregulation of TLR2 and TLR4
Over growth of Propionibacterium acnes
Overrepresentation of Staphylococcus
epidermidis
Chronnell et al., 2001; Cunliffe and
Gollnick, 2001; Jugeau et al., 2005
Atopic
dermatitis
Lower inductions of cathelicidin and hBDs
than those in psoriatic lesional sites despite
the presence of inflammation
Downregulation of cathelicidin and hBDs
following acute wounding
Increased expression of RNase7 and
psoriasin
Frequent bacterial infections
Staphylococcus aureus colonization
Ong et al., 2002; Miller et al., 2005; Harder
et al., 2010; Hata et al., 2010; Mallbris et al.,
2010; Maintz and Novak, 2011
Psoriasis Abnormal expression of cathelicidin and
hBDs
Upregulation of TLR2
Downregulation of TLR5
Infrequency of Propionibacterium and
Actinobacteria species
Predominance of Firmicutes species
Infrequent bacterial infection
Bensch et al., 1995; Ong et al., 2002; Harder
and Schroder, 2005; Miller et al., 2005
Rosacea Abnormal expression of cathelicidin
Abnormal expression of kallikrein 5, which
proteolytically activates hCAP18 to LL-37
Upregulation of TLR2
No pathogenic bacteria found in lesional site
Predominance of S. epidermidis, but inferior
representation of other bacteria
Yamasaki et al., 2007, 2011; Marks, 1968;
Whitfeld et al., 2011
Abbreviations: hBD, human b-defensin; TLR, Toll-like receptor.
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beneficial microflora. This may result in short-term improve-
ment but long-term enhancement of the risks of subsequent
colonization by harmful bacteria. Restoration and main-
tenance of normal microflora may be important to maintain
healthy skin and for management of skin diseases associated
with dysbiosis. As microbial AMPs specifically exert anti-
microbial activity against skin pathogens, but not against
commensals itself, these peptides may have potential to be
safely used as a pathogen-specific antibiotic therapy for skin
infections. In the future, expect exciting new revelations of
the molecular functions of the normal microflora and better
understanding of symbiotic processes between host and our
essential prokaryotic inhabitants.
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